Identification of GPD1L as a Potential Prognosis Biomarker and Associated with Immune Infiltrates in Lung Adenocarcinoma

Figure 4

Analysis of the prognosis of GPD1L in patients with LUAD who were part of the TCGA cohort. Expression of GPD1L has been shown to have a correlation with both (a) overall survival and (b) survival specific to the disease. (c, d) The predictive performance of GPD1L expression in TCGA is evaluated using time-dependent receiver operating characteristic curves.

(a)

(b)

(c)

(d)